The best Side of cancer research
A Better Biomarker for Cancer Immunotherapy? Posted: November 3, 2023 A new study, done largely in mice, may perhaps assistance demonstrate why a at present used molecular marker—called mismatch repair deficiency—doesn’t often perform to predict which clients will respond to immunotherapies referred to as immune checkpoint inhibitors.Research